Caina Technology Co., Ltd.

Shenzhen Stock Exchange 301122.SZ

Caina Technology Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 7.20%

Caina Technology Co., Ltd. Return on Capital Employed (ROCE) is 7.20% for the year ending December 31, 2023, a -31.61% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • Caina Technology Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 10.53%, a -64.34% change year over year.
  • Caina Technology Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 29.53%, a -31.83% change year over year.
  • Caina Technology Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 43.33%, a 64.18% change year over year.
  • Caina Technology Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 26.39%, a 57.08% change year over year.
Key data
Date Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio Return on Common Equity
Market news
Shenzhen Stock Exchange: 301122.SZ

Caina Technology Co., Ltd.

CEO Mr. Jun Lu
IPO Date Jan. 26, 2022
Location China
Headquarters No. 23, Huaxi Road
Employees 689
Sector Health Care
Industries
Pharmaceuticals Biotechnology Medical Instruments
Description

Caina Technology Co., Ltd. engages in the research, development, production, and sale of injection needles, syringes and other related medical devices. It offers disposable sterile safe self-destructing syringes, disposable insulin syringes, disposable sterile insulin pen needles, disposable sterile blood collection needles, and other sterile medical devices. The company was founded in 2004 and is based in Jiangyin, China.

StockViz Staff

January 16, 2025

Any question? Send us an email